Production of substances with thymosin-like activity by B- and T-lymphocytes. 1990

I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
Kiev Research Institute for Roentgenology-Radiology and Oncology, Laboratory of Clinical Immunology, USSR.

The authors investigated the ability of various lymphocyte subpopulations to synthesize substances with thymosin-like activity under the influence of thymostimulin, a preparation of active thymic factors. Experiments carried out on T- and B-mice revealed that only T-lymphocytes synthesized thymosin-like substances in response to thymostimulin administration. Thus induced substances differed significantly from those which ensure the serum activity of normal animals in that their thermostability is by far greater. The feasibility was also explored of inducing by thymosin the in vitro synthesis of substances with thymosin-like activity in cells derived from a variety of lymphoid formations of thymectomized mice. The serum of thymectomized lethally irradiated recipients of lymph node and spleen cells pretreated with thymostimulin was found to contain, 4 h after the transfer, relatively high levels of substances with thymosin-like activity. Contrariwise, the pretreatment of bone marrow cells with thymostimulin resulted in declined levels of substances with thymosin-like activity in recipient sera as compared to those in B-mice which were given untreated bone marrow cells. The incubation of bone marrow cells in a medium containing substances with thymosin-like activity caused a decrease in that activity. Thus, the biologically active thymic factors were shown to induce the synthesis by T-cells of substances with thymosin-like activity.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013934 Thymectomy Surgical removal of the thymus gland. (Dorland, 28th ed) Thymectomies
D013949 Thymus Extracts Extracts of the THYMUS GLAND that contain specific factors, peptides, and proteins with specific biological activities. Thymus Extract,Extract, Thymus,Extracts, Thymus

Related Publications

I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
May 1984, Proceedings of the National Academy of Sciences of the United States of America,
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
July 1977, Immunology,
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
May 1987, European journal of immunology,
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
April 1977, Journal of immunology (Baltimore, Md. : 1950),
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
July 1984, Experimental and clinical endocrinology,
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
June 1975, Annals of the New York Academy of Sciences,
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
September 1984, Cellular immunology,
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
February 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
February 1999, Zhonghua nei ke za zhi,
I S Nikolsky, and T N Seleznyova, and G A Zamotayeva, and S V Martynenko, and Grinevich YuA
November 1974, The Journal of experimental medicine,
Copied contents to your clipboard!